Analytical Market Research’s Post

Global #Genome #Editing Market: By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery, Gene-modified Cell Therapy, Diagnostics, and Other Applications), By Technology (CRISPR, TALEN, ZFN, and Other Technologies), By End User (Academics & Government Institutes, Biotechnology & Pharma Companies, and Contract Research Organizations), and Region : Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030. By: Analytical Market Research Read More Info:https://lnkd.in/dVdCccsT Key Players: CRISPR Therapeutics , GenScript , Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, PerkinElmer., Eurofins Scientific Finland Oy, Danaher Corporation, Editas Medicine, AL Group Lonza . #marketgrowth #marketshare #marketsize #marketdemands #marketforecast #marketstretargy #marketanalysis #markettrends #market

Oligonucleotides play a critical role in today's biotechnology and medical research, driving advancements in diagnostics, therapeutics, and genetic analysis. In a recent interview with Rizwan Chaudhrey, SK pharmteco's Marc J Jacob, Ph.D. shares our latest capabilities in oligonucleotides.   #biotech #biomanufacturing #advancedtherapies

#Biorepositories that collect, process, and store #biospecimens such as tissues, blood, DNA, and cells at subzero temperatures are crucial for advancing drug research, development, and manufacturing. These facilities ensure the integrity of essential biological materials, facilitating breakthroughs in understanding disease mechanisms and accelerating the development of #innovativetherapies. When establishing a #biorepository, #biotechnology and #pharmaceutical companies have two choices: They can either construct one from scratch, or they can purchase space in an existing facility. Our new article breaks down this topic, exploring the advantages of building vs. buying a biorepository. It also discusses how #CDMO partners like Thermo Fisher Scientific can provide storage support. You can read it here: http://spr.ly/6049jU6WZ

💊 𝙁𝙧𝙤𝙢 𝙝𝙞𝙜𝙝 𝙩𝙝𝙧𝙤𝙪𝙜𝙝𝙥𝙪𝙩 𝙨𝙘𝙧𝙚𝙚𝙣𝙞𝙣𝙜 𝙩𝙤 𝘼𝙄: 𝙩𝙝𝙚 𝙦𝙪𝙚𝙨𝙩 𝙩𝙤 𝙩𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢 𝙥𝙝𝙖𝙧𝙢𝙖𝙘𝙚𝙪𝙩𝙞𝙘𝙖𝙡 𝙍&𝘿 💻 Check out this new article from my colleague Philippe Peltier on the quest to transform pharmaceutical R&D (link in comments) Looking back to his past as a #biotech investor and having witnessed several innovation waves (including: high throughput screening, combinatorial chemistry or gene editing), he attemps to draw a parallel with today's excitement over #AI. As investors we look towards the future... but it's always good to keep history in mind too. If you like the article and/or are building in the #biotech, #healthtech or #techbio space, please reach out to us at Kurma Partners!

In this new Cell & Gene article, BioPhorum discusses how #cellandgenetherapy companies can use prior knowledge and platforms to leverage process characterization to reduce the testing and/or studies required during process validation for drug substance and drug product manufacturing processes. https://lnkd.in/e-6-6AZT #cellandgenetherapies #processdevelopment #biotech BioPhorum Advanced Therapy Medicinal Products

As Advanced Therapy Medicinal Products and Cell and Gene Therapies redefine the pharmaceutical industry, the complexity of manufacturing has escalated. Companies are grappling with maintaining quality, efficacy, and compliance while managing soaring costs. At L7 Informatics, we turn these challenges into opportunities with L7|ESP® and L7 MES. Our platform embodies FAIR data principles, ensuring your data is Findable, Accessible, Interoperable, and Reusable. With L7|ESP and the integrated L7 MES, a robust tool for managing manufacturing execution processes, you can enhance your decision-making, streamline manufacturing processes, and ensure compliance while cutting costs. ▶ Join us at PMWS 2024, Booth #28, to see how L7 can revolutionize your operations by: - Accelerating tech transfers. - Contextualizing data seamlessly. - Generating real-time business insights. - Maintaining regulatory compliance. - Reducing costs significantly compared to traditional solutions. See you there! #PMWS2024 #PharmaceuticalManufacturing #DataManagement

Based on the Global #Cell_Based_Assays Market Analysis by Value Market Research: Market Demand to Grow Steadily between 2023 to 2032. >> https://lnkd.in/dyuynNAt Cell-based #assays are experimental techniques for studying #cellular processes, #interactions, and responses to external stimuli or compounds. They involve culturing #cells in vitro and measuring specific cellular #functions, such as proliferation, viability, #apoptosis, migration, differentiation, or #gene expression. These assays are widely used in basic research, #drug discovery, toxicity #testing, and drug screening to investigate disease #mechanisms, evaluate drug efficacy and #safety, and identify potential #therapeutic targets or compounds. Danaher Corporation GE HealthCare Charles River Laboratories AL Group Lonza Thermo Fisher Scientific Merck Group PerkinElmer Cell Signaling Technology (CST) Becton Dickenson Promega Corporation Cell Based Assays #healthcareindustry #pharmaceuticalindustry #healthcareresearch #biotechnology #assays #cellular #gene #research